DHR - DANAHER CORP /DE/


197.14
0.640   0.325%

Share volume: 2,608,685
Last Updated: 04-25-2025
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$196.50
0.64
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
60%
Profitability 57%
Dept financing 44%
Liquidity 27%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
0.42%
1 Month
-4.23%
3 Months
-20.46%
6 Months
-19.24%
1 Year
-20.13%
2 Year
-16.79%
Key data
Stock price
$197.14
P/E Ratio 
39.08
DAY RANGE
$193.95 - $198.28
EPS 
$5.18
52 WEEK RANGE
$171.00 - $281.70
52 WEEK CHANGE
-$20.13
MARKET CAP 
147.123 B
YIELD 
0.55%
SHARES OUTSTANDING 
715.670 M
DIVIDEND
$0.32
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,020,309
AVERAGE 30 VOLUME 
$5,038,408
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 2006
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news
loading